KLOW
KPV + GHK‑Cu + BPC‑157 + TB‑500 Research Blend
Also referenced as: KPV + GHK-Cu + BPC-157 + TB-500 Blend · Four-Peptide Recovery Blend · Multi-pathway Research Peptide Stack
TestingAwaiting Testing
≥99% Purity
Full Panel COA
UPS 2-Day Air
Shipment Insurance Included
Certificate Of Analysis
| Test | Result | Status |
|---|---|---|
| Identity & Purity (Avg, HPLC + MS) | — | Pending |
| Net Peptide Weight (Avg) | — | Pending |
| Heavy Metals (ICP-MS) | — | Pending |
| Endotoxins (LAL Assay) | — | Pending |
| Sterility (DNA Microarray) | — | Pending |
Made in cGMP- and ISO-certified facilities our supply chain has vetted in person, then independently multi-lab tested by Virtus with a final Certificate of Analysis from ILS Laboratories. We pay more to source this way because we hold the highest standard for the product and for you.
View the full Certificate of Analysis →Curated research on KLOW
Singh M (2007). KPV, a peptide derived from alpha-MSH, suppresses inflammation in models of colitis World J Gastroenterol.
PMID: 17786027 →Pickart L (2015). GHK-Cu may prevent oxidative stress in skin by regulating copper and modifying expression of numerous antioxidant genes Cosmetics.
PMID: 25529770 →Sikiric P (2014). BPC 157 enhances the healing of wounds in rats and stimulates angiogenesis J Physiol Pharmacol.
PMID: 24446478 →Sosne G (2010). Thymosin beta-4 induces collagen synthesis and tissue repair in cardiac fibroblasts Ann N Y Acad Sci.
PMID: 22416770 →
About KLOW
A four-peptide research blend combining KPV (10mg), GHK-Cu (50mg), BPC-157 (10mg), and TB-500 (10mg) in a single 80mg lyophilized vial. KLOW is investigated in preclinical research for its multi-pathway profile across inflammatory modulation, extracellular matrix remodeling, angiogenesis, and actin-driven cellular migration.
Each component is associated in published literature with a distinct mechanistic pathway: copper-dependent ECM-related signaling (GHK-Cu), inflammatory pathway modulation (KPV), angiogenesis pathway markers (BPC-157), and actin-driven cell-migration assays (TB-500). KLOW combines these four research compounds into a single formulation for laboratory studies of tissue support and regenerative pathways at the cellular level.
Also Referenced As
KPV + GHK-Cu + BPC-157 + TB-500 Blend · Four-Peptide Recovery Blend · Multi-pathway Research Peptide Stack
Specifications
- Scientific Name
- KPV + GHK-Cu + BPC-157 + TB-500: Four-Peptide Research Blend
- CAS Number
- 67727-97-3 / 49557-75-7 / 137525-51-0 / 77591-33-4
- Molecular Formula
- KPV C₁₆H₃₀N₄O₄ · GHK-Cu C₁₄H₂₄CuN₆O₄ · BPC-157 C₆₂H₉₈N₁₆O₂₂ · TB-500 C₂₁₂H₃₅₀N₅₆O₇₈S
- Molecular Weight
- Blend: KPV 342.4 g/mol · GHK-Cu 403.9 g/mol · BPC-157 1419.54 g/mol · TB-500 4963.49 g/mol
- Physical Form
- Lyophilized powder
- Purity
- Coming Soon
- Batch Number
- TBD
- Storage
- −20°C, protected from light, avoid repeated freeze-thaw cycles
Storage & Handling
Lyophilized peptides remain stable for 12–24 months when stored properly. Follow standard laboratory protocols for handling.
Storage
Store lyophilized peptide at −20°C in a standard laboratory freezer, protected from light, moisture, and heat. Avoid repeated freeze-thaw cycles.
Shelf Life
Lyophilized form remains stable for 12–24 months at −20°C in the original sealed vial. Always reference the batch-specific COA for verified shelf-life data.
Mechanism & Research Background
KLOW is a four-component peptide blend supplied as 80mg total per vial: KPV (10mg), GHK-Cu (50mg), BPC-157 (10mg), and TB-500 (10mg). Each component has been independently characterized in research literature across distinct biological pathways relevant to tissue support and regenerative cellular processes.
GHK-Cu (Glycyl-L-Histidyl-L-Lysine copper complex) is a tripeptide that binds copper(II) and is studied in extracellular matrix remodeling research, including effects on collagen and elastin synthesis in fibroblast culture models. KPV (Lysine-Proline-Valine) is a C-terminal fragment of α-MSH studied in inflammatory-pathway research, with reported effects on NF-κB signaling and cytokine modulation in cell-culture and animal models.
BPC-157 (Body Protective Compound-157) is a 15-amino-acid pentadecapeptide derived from a fragment of gastric juice protein, studied in research on vascular stabilization and tissue repair pathways. TB-500 (Thymosin Beta-4 fragment) is a 17-amino-acid actin-sequestering peptide studied in cellular-migration and tissue-organization research. KLOW combines these four research compounds in a single formulation; products supplied by Virtus Peptides are intended exclusively for in-vitro laboratory research and are not for human or animal use.
